GILEAD SCIENCES INC's ticker is and the CUSIP is 375558903. A total of 13 filers reported holding GILEAD SCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $257 | -85.4% | 220,000 | -36.2% | 0.00% | -90.5% |
| Q1 2023 | $1,765 | +71.5% | 345,000 | -68.6% | 0.02% | +61.5% |
| Q4 2022 | $1,029 | -99.7% | 1,100,000 | +36.3% | 0.01% | +160.0% |
| Q3 2022 | $398,000 | -77.6% | 807,000 | +5.2% | 0.01% | -73.7% |
| Q2 2022 | $1,773,000 | +5619.4% | 767,000 | +4411.8% | 0.02% | – |
| Q1 2022 | $31,000 | +933.3% | 17,000 | -72.4% | 0.00% | – |
| Q4 2020 | $3,000 | -87.0% | 61,500 | 0.0% | 0.00% | – |
| Q3 2020 | $23,000 | -97.3% | 61,500 | -70.9% | 0.00% | -100.0% |
| Q2 2020 | $858,000 | +483.7% | 211,500 | -52.3% | 0.01% | +600.0% |
| Q4 2019 | $147,000 | -26.1% | 443,800 | -25.6% | 0.00% | -50.0% |
| Q3 2019 | $199,000 | -71.1% | 596,300 | +30.0% | 0.00% | -60.0% |
| Q2 2019 | $688,000 | +80.6% | 458,800 | +56.2% | 0.01% | +25.0% |
| Q1 2019 | $381,000 | -41.0% | 293,800 | -75.4% | 0.00% | -33.3% |
| Q4 2018 | $646,000 | -81.6% | 1,196,200 | +6.7% | 0.01% | -76.9% |
| Q3 2018 | $3,503,000 | +32.6% | 1,121,200 | +6.2% | 0.03% | +8.3% |
| Q2 2018 | $2,641,000 | -45.2% | 1,056,200 | -15.0% | 0.02% | -38.5% |
| Q1 2018 | $4,821,000 | +127.9% | 1,242,100 | -3.3% | 0.04% | +95.0% |
| Q4 2017 | $2,115,000 | -67.0% | 1,284,100 | -7.8% | 0.02% | -64.3% |
| Q3 2017 | $6,418,000 | +139.0% | 1,392,700 | +16.9% | 0.06% | +133.3% |
| Q2 2017 | $2,685,000 | +324.2% | 1,190,900 | +136.5% | 0.02% | +300.0% |
| Q1 2017 | $633,000 | -1.2% | 503,500 | -48.2% | 0.01% | +20.0% |
| Q4 2016 | $641,000 | +268.4% | 972,200 | +66.9% | 0.01% | +150.0% |
| Q3 2016 | $174,000 | -68.1% | 582,600 | -14.6% | 0.00% | -50.0% |
| Q2 2016 | $546,000 | -51.8% | 682,600 | +88.4% | 0.00% | -50.0% |
| Q1 2016 | $1,133,000 | -71.5% | 362,400 | -36.8% | 0.01% | -71.4% |
| Q4 2015 | $3,980,000 | -10.1% | 573,000 | -22.8% | 0.03% | +7.7% |
| Q3 2015 | $4,425,000 | -56.4% | 742,200 | +13.4% | 0.03% | -61.2% |
| Q2 2015 | $10,139,000 | +154.6% | 654,600 | +183.9% | 0.07% | +179.2% |
| Q1 2015 | $3,983,000 | -0.1% | 230,600 | -4.7% | 0.02% | +20.0% |
| Q4 2014 | $3,985,000 | -36.6% | 242,000 | 0.0% | 0.02% | -45.9% |
| Q3 2014 | $6,282,000 | +210.4% | 242,000 | +69.8% | 0.04% | +208.3% |
| Q2 2014 | $2,024,000 | +736.4% | 142,500 | -41.4% | 0.01% | +1100.0% |
| Q1 2014 | $242,000 | -92.9% | 243,100 | +12.4% | 0.00% | -92.9% |
| Q4 2013 | $3,395,000 | +94.0% | 216,300 | -10.4% | 0.01% | +100.0% |
| Q3 2013 | $1,750,000 | +1090.5% | 241,500 | +1304.1% | 0.01% | +600.0% |
| Q2 2013 | $147,000 | – | 17,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 963,700 | $67,314,000 | 1.98% |
| PURA VIDA INVESTMENTS, LLC | 150,000 | $10,478,000 | 0.32% |
| Capital Markets Trading UK LLP | 245,200 | $17,394,000 | 0.23% |
| GROUP ONE TRADING, L.P. | 1,338,800 | $93,515,000 | 0.10% |
| SIMPLEX TRADING, LLC | 757,000 | $52,331,000 | 0.05% |
| Marathon Trading Investment Management LLC | 4,000 | $279,000 | 0.02% |
| Maven Securities LTD | 5,400 | $377,000 | 0.01% |
| Allianz Asset Management GmbH | 70,900 | $4,952,000 | 0.00% |
| JPMORGAN CHASE & CO | 155,900 | $10,890,000 | 0.00% |
| CIBC WORLD MARKETS CORP | 2,000 | $140,000 | 0.00% |